Large-scale cardiovascular outcome trials (CVOTs) have shown that glucagon-like peptide-1 receptor agonists (GLP-1RAs) significantly reduce major adverse cardiovascular events (MACE), redefining cardiometabolic risk management and influencing contemporary therapeutic strategies
[13] GLP-1 medication use by age in the UK The median age of Mounjaro users in the UK is 44 years old, with those aged between 40 and 59 making up more than half of all users (53.5%)
Before your first visit, youll complete a short online questionnaire about your health history so we can make sure treatment is safe and right for you
It can be rather irritating and, if improperly controlled, cause hair loss
Glucagon-like peptide-1 cleavage product GLP-1(9-36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes
Its role in weight loss is particularly notable, with trials showing that it surpasses the effects of both tirzepatide and semaglutide in reducing body fat